Effect of interferential current on TNF Alpha and chemotherapy induced neuropathic pain.
- Conditions
- G13.0*Paraneoplastic neuromyopathy and neuropathy.Paraneoplastic neuromyopathy and neuropathy
- Registration Number
- IRCT201502164203N9
- Lead Sponsor
- Vice-chancellor for research- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria:Patients receiving chemotherapy drugs with Paclitaxel or Oxaliplatin and passed at least four weeks of chemotherapy treatment; Age greater than 18 years ; Are expected to live more than three months; Average daily pain score greater than 5.
Receiving the first dose of chemotherapy drug is less than four weeks or neuropathic pain is a cause other than chemotherapy; Detection of metastases to the brain or spinal cord; the patient to other research related to pain within 30 days, non-intervention previous intervention plan for pain control; pregnant women or active use of birth control pills; having coronary artery disease within 6 months; history of seizures; any form of metal medical devices such as pacemakers for heart patients; the bad condition of the skin, placing electrodes on the skin to prevent those things near the tumor or acute bacterial infection is present; patients before the end of the plan will require re-treatment chemotherapy.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemotherapy induced neuropathic pain. Timepoint: Before intervention, after 10 sessins of intervention. Method of measurement: Visual analogue scale(vas).
- Secondary Outcome Measures
Name Time Method Serum TNF a level. Timepoint: Before intervention, after 10 sessions of intervention. Method of measurement: measurement kit of the TNF a.